Staar Surgical (STAA) Stock Forecast & Price Target

Compare

545 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

STAA Analyst Ratings

Hold

2 Buy

7 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Staar

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

STAA Stock 12 Month Forecast

Average Price Target

$19.14

▲(9.75%Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Staar Surgical in the last 3 months. The average price target is $19.14 with a high forecast of $27.00 and a low forecast of $13.00. The average price target represents a 9.75% change from the last price of $17.44.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","21":"$21","30":"$30","39":"$39","48":"$48"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,21,30,39,48],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.69,17.483076923076926,18.276153846153846,19.06923076923077,19.862307692307695,20.655384615384616,21.44846153846154,22.24153846153846,23.034615384615385,23.82769230769231,24.62076923076923,25.413846153846155,26.206923076923076,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.69,16.87846153846154,17.06692307692308,17.255384615384617,17.443846153846156,17.632307692307695,17.82076923076923,18.00923076923077,18.197692307692307,18.386153846153846,18.574615384615385,18.763076923076923,18.951538461538462,{"y":19.14,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.69,16.40615384615385,16.122307692307693,15.838461538461539,15.554615384615385,15.27076923076923,14.986923076923077,14.703076923076924,14.419230769230769,14.135384615384616,13.85153846153846,13.567692307692308,13.283846153846154,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":41.53,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.42,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.09,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.88,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.56,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.72,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.29,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.19,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.5,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.6,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.34,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$27.00

Average Price Target$19.14

Lowest Price Target$13.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$18

Hold

3.21%

Upside

Reiterated

06/12/25

The overall stock score reflects significant challenges in financial performance with declining revenues and negative margins as the most impactful factors. While corporate events and strategic initiatives provide a positive outlook, technical indicators and valuation metrics caution about potential risks. The company needs to address operational and profitability issues to improve investor sentiment.

Margaret KaczorWilliam Blair

William Blair

―

Hold

―

Reiterated

06/05/25

Cautious Optimism for Staar Surgical Amidst Uncertain Macroeconomic Recovery and Market Shifts

John Young CFACanaccord Genuity

Canaccord Genuity

$20

Hold

14.68%

Upside

Initiated

05/23/25

Staar Surgical (STAA) Receives a Hold from Canaccord Genuity

David SaxonNeedham

Needham

―

Hold

―

Reiterated

05/21/25

Cautious Hold Rating on Staar Surgical Amid Modest Improvements in Chinese Market

Raj DenhoyJefferies

Jefferies

$18→$21

Hold

20.41%

Upside

Reiterated

05/19/25

STAAR Surgical (STAA) PT Raised to $21 at JefferiesJefferies analyst Raj Denhoy raised the price target on STAAR Surgical (NASDAQ: STAA) to $21.00 (from $18.00) while maintaining a Hold rating.

James SidotiSidoti

Sidoti

$27

Buy

54.82%

Upside

Reiterated

05/08/25

Patrick WoodMorgan Stanley

Morgan Stanley

$13

Sell

-25.46%

Downside

Reiterated

05/08/25

Cautious Outlook on Staar Surgical Amid Market Challenges and Guidance Withdrawal

Thomas StephanStifel Nicolaus

Stifel Nicolaus

$20

Buy

14.68%

Upside

Reiterated

05/08/25

Staar Surgical (STAA) Gets a Buy from Stifel Nicolaus

Matthew O'BrienPiper Sandler

Piper Sandler

$16

Hold

-8.26%

Downside

Reiterated

05/08/25

Piper Sandler Keeps Their Hold Rating on Staar Surgical (STAA)

Unknown AnalystWells Fargo

Not Ranked

Wells Fargo

$17

Hold

-2.52%

Downside

Initiated

04/21/25

Wells Fargo starts STAAR Surgical (STAA) at Equal WeightWells Fargo initiates coverage on STAAR Surgical (NASDAQ: STAA) with a Equal Weight rating and a price target of $17.00.

Ryan ZimmermanBTIG

BTIG

―

Hold

―

Reiterated

03/17/25

BTIG Keeps Their Hold Rating on Staar Surgical (STAA)

Anthony PetroneMizuho Securities

Mizuho Securities

$45→$17

Hold

-2.52%

Downside

Downgraded

02/12/25

Staar Surgical downgraded to Neutral from Outperform at MizuhoStaar Surgical downgraded to Neutral from Outperform at Mizuho

Steven LichtmanOppenheimer

Oppenheimer

―

Hold

―

Reiterated

11/01/24

Oppenheimer Reaffirms Their Hold Rating on Staar Surgical (STAA)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$18

Hold

3.21%

Upside

Reiterated

06/12/25

Margaret KaczorWilliam Blair

William Blair

―

Hold

―

Reiterated

06/05/25

Cautious Optimism for Staar Surgical Amidst Uncertain Macroeconomic Recovery and Market Shifts

John Young CFACanaccord Genuity

Canaccord Genuity

$20

Hold

14.68%

Upside

Initiated

05/23/25

Staar Surgical (STAA) Receives a Hold from Canaccord Genuity

David SaxonNeedham

Needham

―

Hold

―

Reiterated

05/21/25

Cautious Hold Rating on Staar Surgical Amid Modest Improvements in Chinese Market

Raj DenhoyJefferies

Jefferies

$18→$21

Hold

20.41%

Upside

Reiterated

05/19/25

STAAR Surgical (STAA) PT Raised to $21 at JefferiesJefferies analyst Raj Denhoy raised the price target on STAAR Surgical (NASDAQ: STAA) to $21.00 (from $18.00) while maintaining a Hold rating.

James SidotiSidoti

Sidoti

$27

Buy

54.82%

Upside

Reiterated

05/08/25

Patrick WoodMorgan Stanley

Morgan Stanley

$13

Sell

-25.46%

Downside

Reiterated

05/08/25

Cautious Outlook on Staar Surgical Amid Market Challenges and Guidance Withdrawal

Thomas StephanStifel Nicolaus

Stifel Nicolaus

$20

Buy

14.68%

Upside

Reiterated

05/08/25

Staar Surgical (STAA) Gets a Buy from Stifel Nicolaus

Matthew O'BrienPiper Sandler

Piper Sandler

$16

Hold

-8.26%

Downside

Reiterated

05/08/25

Piper Sandler Keeps Their Hold Rating on Staar Surgical (STAA)

Unknown AnalystWells Fargo

Not Ranked

Wells Fargo

$17

Hold

-2.52%

Downside

Initiated

04/21/25

Wells Fargo starts STAAR Surgical (STAA) at Equal WeightWells Fargo initiates coverage on STAAR Surgical (NASDAQ: STAA) with a Equal Weight rating and a price target of $17.00.

Ryan ZimmermanBTIG

BTIG

―

Hold

―

Reiterated

03/17/25

BTIG Keeps Their Hold Rating on Staar Surgical (STAA)

Anthony PetroneMizuho Securities

Mizuho Securities

$45→$17

Hold

-2.52%

Downside

Downgraded

02/12/25

Staar Surgical downgraded to Neutral from Outperform at MizuhoStaar Surgical downgraded to Neutral from Outperform at Mizuho

Steven LichtmanOppenheimer

Oppenheimer

―

Hold

―

Reiterated

11/01/24

Oppenheimer Reaffirms Their Hold Rating on Staar Surgical (STAA)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Staar Surgical

1 Month

xxx

Success Rate

5/12 ratings generated profit

Average Return

-3.09%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 41.67% of your transactions generating a profit, with an average return of -3.09% per trade.

3 Months

xxx

Success Rate

2/12 ratings generated profit

Average Return

-11.92%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -11.92% per trade.

1 Year

Thomas StephanStifel Nicolaus

Success Rate

1/12 ratings generated profit

Average Return

-40.19%

reiterated a buy rating last month

Copying Thomas Stephan's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -40.19% per trade.

2 Years

xxx

Success Rate

1/12 ratings generated profit

Average Return

-40.91%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 8.33% of your transactions generating a profit, with an average return of -40.91% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

STAA Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, STAA has received 2 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. STAA average Analyst price target in the past 3 months is 19.14.

Each month's total comprises the sum of three months' worth of ratings.

STAA Financial Forecast

STAA Earnings Forecast

Next quarter’s earnings estimate for STAA is -$0.58 with a range of -$0.70 to -$0.39. The previous quarter’s EPS was -$0.52. STAA beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.44% of the time in the same period. In the last calendar year STAA has Outperformed its overall industry.

STAA Sales Forecast

Next quarter’s sales forecast for STAA is $40.87M with a range of $39.20M to $45.00M. The previous quarter’s sales results were $42.59M. STAA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 38.64% of the time in the same period. In the last calendar year STAA has Outperformed its overall industry.

STAA Stock Forecast FAQ

What is STAA’s average 12-month price target, according to analysts?

Based on analyst ratings, Staar Surgical’s 12-month average price target is 19.14.

What is STAA’s upside potential, based on the analysts’ average price target?

Staar Surgical has 9.75% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is STAA a Buy, Sell or Hold?

Staar Surgical has a consensus rating of Hold which is based on 2 buy ratings, 7 hold ratings and 1 sell ratings.

What is Staar Surgical’s price target?

The average price target for Staar Surgical is 19.14. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $27.00 ,the lowest forecast is $13.00. The average price target represents 9.75% Increase from the current price of $17.44.

What do analysts say about Staar Surgical?

Staar Surgical’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of STAA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Staar Surgical (STAA) Stock Forecast & Price Target

STAA Analyst Ratings

STAA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Staar Surgical

STAA Analyst Recommendation Trends

STAA Financial Forecast

STAA Earnings Forecast

STAA Sales Forecast

STAA Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts